Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02915549 · ClinicalTrials.gov registry record · NA
Early Progressive Feeding in Human-Milk Fed Extremely Preterm Infants: A Randomized Trial
A NA study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT02915549: Completed NA study, sponsored by University of Alabama at Birmingham.
NCT02915549 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02915549, a NA study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
To test the hypothesis that progressive feeding without minimal enteral feeding (MEF) compared to progressive feeding preceded by a 4-day course of MEF will result in an increased number of days alive on full enteral feeding in the first 28 days after birth in extremely preterm infants receiving human milk.
Primary Outcome
number of days alive on full enteral feeding in the first 28 days after birth
Interventions
- OTHER Progressive Feeding without MEF
- OTHER Progressive Feeding with MEF
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2016-09 |
| Est. Completion | 2022-11 |
| Phase | NA |
What the finished NCT02915549 record still lists
NCT02915549 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which Progressive Feeding without MEF is the first listed.
NCT02915549 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02915549 about?
NCT02915549 is a clinical study titled "Early Progressive Feeding in Human-Milk Fed Extremely Preterm Infants: A Randomized Trial". To test the hypothesis that progressive feeding without minimal enteral feeding (MEF) compared to progressive feeding preceded by a 4-day course of MEF will result in an increased number of days alive on full enteral feeding in the first 28 days after birth in extremely preterm infants receiving hum...
What is the current status of trial NCT02915549?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2016-09. Estimated completion is 2022-11.
What interventions are being tested in trial NCT02915549?
The interventions under investigation include: Progressive Feeding without MEF (OTHER), Progressive Feeding with MEF (OTHER).
Who is sponsoring clinical trial NCT02915549?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02915549's enrollment target sits among peer trials
60 1164th of 2000 higher than 745 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia